36
ICCS 2011
TUESDAY, OCTOBER 18 - PM
1:30 - 4:30 PM
Grand Ballroom II
Plenary Session V - Translational Medicine
Chair(s): Virginia Litwin
1:30
Of Mice, Men, and Monkeys: Flow
Cytometry-Based Biomarkers to
Inform each Stage of rhuMAb Beta7
Drug Development
Marna Williams
Genentech, Inc. and F. Hoffmann-La
Roche Ltd, USA
2:10
Validation of a Flow Cytometry-Based
G2-M Delay Cell Cycle Assay for Use
in Evaluating the Pharmacodynamic
Response to Aurora A Inhibition
Jose Estevam
Millennium, USA
2:50
COFFEE BREAK
3:10
Phosphoflow- Lead Optimization
through Pre-clinical Development in
Drug Discovery
Becky Penhallow
Bristol Myers Squibb, USA
3:50
P-Flow Related to Oncology Drug
Development
Shabnam Tangri
Biogen idec, USA
4:30 - 6:00 PM
Grand Ballroom II
CSI Case Study Interpretations
4:30
CSI Case Study Interpretations
David Grier
Wake Forest University, USA
4:50
CSI Case Study Interpretations
Mihai Merzianu
Roswell Park Cancer Institute, USA
5:10
CSI Case Study Interpretations
Mikhail Roshal
Cornell, USA
5:30
CSI Case Study Interpretations
Prashant Tembhare
NIH, USA